Amelioration of cardiac remodeling in congestive heart failure by β-adrenoceptor blockade is associated with depression in sympathetic activity

Cardiovascular Toxicology

Volumn 10, Issue 1, 2010, Pages 9-16

  MacHackova, Jarmila ^a,b   Sanganalmath, Santosh K ^a,b   Barta, Judit ^a,b   Dhalla, Ken S ^a,b   Dhalla, Naranjan S ^a,b  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Adrenoceptor antagonists; Cardiac dysfunction; Cardiac hypertrophy and failure; Plasma catecholamines

Indexed keywords

ADRENALIN; ATENOLOL; CATECHOLAMINE; NORADRENALIN; PROPRANOLOL;

ADRENALIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CATECHOLAMINE BLOOD LEVEL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG MEGADOSE; DRUG OVERDOSE; ELECTROCARDIOGRAPHY; HEART DILATATION; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART OUTPUT; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; LOW DRUG DOSE; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PULSE RATE; QT PROLONGATION; RAT; SYMPATHETIC TONE;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ATENOLOL; BLOOD PRESSURE; DEPRESSION, CHEMICAL; ELECTROCARDIOGRAPHY; EPINEPHRINE; HEART FAILURE; HEART RATE; MALE; NOREPINEPHRINE; ORGAN SIZE; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR REMODELING;

RATTUS;

EID: 77951130241     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12012-009-9058-y     Document Type: Article

References (33)

1. MA Pfeffer E Braunwald 1990 Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications Circulation 81 1161 1172 1:STN:280:DyaK3c3gtVWjsQ%3D%3D 2138525 (Pubitemid 20119612)
2. NS Dhalla MR Dent PS Tappia R Sethi J Barta RK Goyal 2006 Subcellular remodeling as a viable target for the treatment of congestive heart failure Journal of Cardiovascular Pharmacology and Therapeutics 11 31 45 10.1177/107424840601100103 1:CAS:528:DC%2BD28XjvF2msrY%3D 16703218
3. M Esler D Kaye 2005 Measurement of sympathetic nervous system activity in heart failure: The role of norepinephrine kinetics Heart Failure Reviews 5 17 25 (Pubitemid 30301508)
4. A Adameova Y Abdellatif NS Dhalla 2009 Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease Canadian Journal of Physiology and Pharmacology 87 493 514 10.1139/Y09-042 1:CAS:528:DC%2BD1MXhtVSjsrnO 19767873
5. HN Sabbah 1999 The cellular and physiologic effects of β-blockers in heart failure Clinical Cardiology 22 Suppl 5 V16 V20 10526699
6. JM Brophy L Joseph JL Rouleau 2001 β-blockers in congestive heart failure. A Bayesian meta-analysis Annals of Internal Medicine 134 550 560 1:CAS:528:DC%2BD3MXivVaju7Y%3D 11281737 (Pubitemid 32245316)
7. JG Cleland MR Bristow E Erdmann WJ Remme K Swedberg F Waagstein 1996 β-blocking agents in heart failure. Should they be used and how? European Heart Journal 17 1629 1639 1:CAS:528:DyaK28XmvFSqt7c%3D 8922910 (Pubitemid 26381820)
8. K Hu P Gaudron G Ertl 1998 Long-term effects of β-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: Importance of timing of treatment and infarct size Journal of the American College of Cardiology 31 692 700 10.1016/S0735-1097(97)00527-5 1:CAS:528:DyaK1cXhvVyksrc%3D 9502655 (Pubitemid 28144139)
9. PA Heidenreich TT Lee BM Massia 1997 Effect of β-blockade on mortality in patients with heart failure: A meta-analysis of randomized clinical trials Journal of the American College of Cardiology 30 27 34 10.1016/S0735-1097(97)00104-6 1:CAS:528:DyaK2sXks1Kqsrg%3D 9207617 (Pubitemid 27357123)
10. DW Exner DL Dries MA Waclawiw B Shelton MJ Domanski 1999 β-adrenergic blocking agent used and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A post hoc analysis of the Studies of Left Ventricular Dysfunction Journal of the American College of Cardiology 33 916 923 10.1016/S0735-1097(98)00675-5 1:CAS:528:DyaK1MXntVWgurw%3D 10091816
11. 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: Coupling of both receptor subtypes to muscle contraction and selective β1-receptor down-regulation in heart failure Circulation Research 59 297 309 1:CAS:528:DyaL2sXkvVSgsw%3D%3D 2876788 (Pubitemid 17178124)
12. F Waagstein K Caidahl I Wallentin CH Bergh A Hjalmarson 1989 Long-term β-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol Circulation 80 551 563 1:STN:280:DyaL1MzlsFensw%3D%3D 2548768 (Pubitemid 19231389)
13. M Hulsmann B Sturm R Pacher R Berger A Bojic B Frey, et al. 2001 Long-term effect of atenolol on ejection fraction, symptoms, and exercise variables in patients with advanced left ventricular dysfunction The Journal of Heart and Lung Transplantation 20 1174 1180 10.1016/S1053-2498(01)00341-2 1:STN:280:DC%2BD3Mnlt1KgsA%3D%3D 11704477 (Pubitemid 33035079)
14. AV Mattioli MG Modena G Fantini G Mattioli 1990 Atenolol in dilated cardiomyopathy: A clinical instrumental study Cardiovascular Drugs and Therapy 4 505 507 10.1007/BF01857761 1:STN:280:DyaK3M7jslaktw%3D%3D 2285633 (Pubitemid 20208404)
15. ER Maia H Villacorta CG Subietta C Munhoz LJ Romeo Filho ET Mesquita 2001 Use of propranolol in heart failure patients: Safety, tolerability, and effects on left ventricular function Revista Portuguesa de Cardiologia 20 383 399 1:STN:280:DC%2BD38%2Fhslajtg%3D%3D 11433884
16. R Lampert JR Ickovics CJ Viscoli RI Horwitz FA Lee 2003 Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the β-Blocker Heart Attack Trial The American Journal of Cardiology 91 137 142 10.1016/S0002-9149(02)03098-9 1:CAS:528:DC%2BD3sXotVSm 12521623 (Pubitemid 36084296)
17. HK Saini-Chohan GM Hatch 2009 Biological actions and metabolism of currently used pharmacological agents for the treatment of congestive heart failure Current Drug Metabolism 10 206 219 10.2174/138920009787846314 1:CAS:528:DC%2BD1MXmtlGrsLo%3D 19442083
18. 1-selective and nonselective β-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure Circulation 94 353 358 1:CAS:528: DyaK28XltF2rs7k%3D 8759076
19. ER Azevedo T Kubo S Mak A Al-Hesayen A Schofield R Allan, et al. 2001 Nonselective versus selective β-adrenergic receptor blockade in congestive heart failure: Differential effects on sympathetic activity Circulation 104 2194 2199 10.1161/hc4301.098282 1:CAS:528:DC%2BD3MXptVCru70%3D 11684630 (Pubitemid 33043299)
20. 1-blockade improves cardiac bioenergetics and function and decreases neuroendocrine activation in rats during early postinfarct remodeling Biochemical and Biophysical Research Communications 281 491 498 10.1006/bbrc.2001.4336 1:CAS:528:DC%2BD3MXht1ait7w%3D 11181074 (Pubitemid 32928182)
21. SE Litwin SE Katz JP Morgan PS Douglas 1999 Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure British Journal of Pharmacology 127 1671 1679 10.1038/sj.bjp.0702701 1:CAS:528:DyaK1MXlt1Chur4%3D 10455325 (Pubitemid 29369003)
22. RG Gay TE Raya S Goldman 1990 Chronic propranolol treatment promotes left ventricular dilation without altering systolic function after large myocardial infarction in rats Journal of Cardiovascular Pharmacology 16 529 536 10.1097/00005344-199010000-00003 1:CAS:528:DyaK3cXlvVCmsrY%3D 1706793 (Pubitemid 20305809)
23. MC Fishbein LQ Lei SA Rubin 1998 Long-term propranolol administration alters myocyte and ventricular geometry in rat hearts with and without infarction Circulation 78 369 375
24. BH Oh S Ono E Gilpin J Ross Jr 1993 Altered left ventricular remodeling with β-adrenergic blockade and exercise after coronary reperfusion in rats Circulation 87 608 616 1:CAS:528:DyaK2cXlvFGgu7k%3D 8093867 (Pubitemid 23040931)
25. V Zaca S Rastogi S Mishra M Wang VG Sharov RC Gupta, et al. 2009 Atenolol is inferior to metoprolol in improving left ventricular function and preventing ventricular remodeling in dogs with heart failure Cardiology 112 294 302 10.1159/000159123 1:CAS:528:DC%2BD1MXis12gu7c%3D 18832825
26. IM Dixon SL Lee NS Dhalla 1990 Nitrendipine binding in congestive heart failure due to myocardial infarction Circulation Research 66 782 788 1:CAS:528:DyaK3cXhslKgsbY%3D 2155068 (Pubitemid 20086916)
27. SK Sanganalmath J Barta N Takeda H Kumamoto NS Dhalla 2008 Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction Canadian Journal of Physiology and Pharmacology 86 180 189 10.1139/Y08-005 1:CAS:528:DC%2BD1cXmtVejtrY%3D 18418427 (Pubitemid 351536449)
28. SK Sanganalmath AP Babick J Barta H Kumamoto N Takeda NS Dhalla 2008 Antiplatelet therapy attenuates subcellular remodelling in congestive heart failure Journal of Cellular and Molecular Medicine 12 1728 1738 10.1111/j.1582-4934.2007.00197.x 1:CAS:528:DC%2BD1cXhsVartr7N 18088389
29. T Reffelmann RA Kloner 2003 Transthoracic echocardiography in rats. Evaluation of commonly used indices of left ventricular dimensions, contractile performance, and hypertrophy in a genetic model of hypertrophic heart failure (SHHF-Mcc-facp-Rats) in comparison with Wistar rats during aging Basic Research in Cardiology 98 275 284 10.1007/s00395-003-0401-3 12955400 (Pubitemid 37107654)
30. H Hallman LO Farnebo B Hamberger G Johnsson 1978 A sensitive method for the determination of plasma catecholamines using liquid chromatography with electrochemical detection Life Sciences 23 1049 1052 10.1016/0024-3205(78)90665- 3 1:CAS:528:DyaE1MXisFGg 713684
31. NS Dhalla HK Saini-Chohan D Rodriguez V Elimban MR Dent PS Tappia 2009 Subcellular remodeling may induce cardiac dysfunction in congestive heart failure Cardiovascular Research 81 429 438 10.1093/cvr/cvn281 1:CAS:528:DC%2BD1MXhtlKiurw%3D 18852252
32. S Ahnve C Helmers T Lundman 1980 QTc intervals at discharge after acute myocardial infarction and long-term prognosis Acta Medica Scandinavica 208 55 60 1:STN:280:DyaL3M%2FlvFWktQ%3D%3D 7435248 (Pubitemid 10004162)
33. H Majewski MW McCulloch MJ Rand DF Story 1980 Adrenaline activation of prejunctional β-adrenoceptors in guinea-pig atria British Journal of Pharmacology 71 435 444 1:CAS:528:DyaL3MXitVart7g%3D 6258697 (Pubitemid 11218938)